Generated Narrative: ValueSet eHDSIOncologyDisease Include these codes as defined in http://terminology.hl7.org/CodeSystem/icd-o-3 version Not Stated (use latest from terminology server) Code Display 8000/0 Neoplasm, benign 8000/1 Neoplasm, uncertain whether benign or malignant 8000/3 Neoplasm, malignant 8000/6 Neoplasm, metastatic 8000/9 Neoplasm, malignant, uncertain whether primary or metastatic 8001/0 Tumour cells, benign 8001/1 Tumour cells, uncertain whether benign or malignant 8001/3 Tumour cells, malignant 8002/3 Malignant tumour, small cell type 8003/3 Malignant tumour, giant cell type 8004/3 Malignant tumour, spindle cell type 8005/0 Clear cell tumour, NOS 8005/3 Malignant tumour, clear cell type 8010/0 Epithelial tumour, benign 8010/2 Carcinoma in situ, NOS 8010/3 Carcinoma, NOS 8010/6 Carcinoma, metastatic, NOS 8010/9 Carcinomatosis 8011/0 Epithelioma, benign 8011/3 Epithelioma, malignant 8012/3 Large cell carcinoma, NOS 8013/3 Large cell neuroendocrine carcinoma 8014/3 Large cell carcinoma with rhabdoid phenotype 8015/3 Glassy cell carcinoma 8020/3 Carcinoma, undifferentiated, NOS 8021/3 Carcinoma, anaplastic, NOS 8022/3 Pleomorphic carcinoma 8023/3 Nuclear protein in testis (NUT) associated carcinoma 8030/3 Giant cell and spindle cell carcinoma 8031/3 Giant cell carcinoma 8032/3 Spindle cell carcinoma, NOS 8033/3 Pseudosarcomatous carcinoma 8034/3 Polygonal cell carcinoma 8035/3 Carcinoma with osteoclast-like giant cells 8040/0 Tumourlet, benign 8040/1 Tumourlet, NOS 8041/3 Small cell carcinoma, NOS 8042/3 Oat cell carcinoma 8043/3 Small cell carcinoma, fusiform cell 8044/3 Small cell carcinoma, intermediate cell 8045/3 Combined small cell carcinoma 8046/3 Non-small cell carcinoma 8050/0 Papilloma, NOS 8050/2 Papillary carcinoma in situ 8050/3 Papillary carcinoma, NOS 8051/0 Verrucous papilloma 8051/3 Verrucous carcinoma, NOS 8052/0 Squamous cell papilloma, NOS 8052/2 Papillary squamous cell carcinoma, non-invasive 8052/3 Papillary squamous cell carcinoma 8053/0 Squamous cell papilloma, inverted 8054/0 Warty dyskeratoma 8054/3 Warty carcinoma 8060/0 Squamous papillomatosis 8070/0 Actinic keratosis 8070/2 Squamous cell carcinoma in situ, NOS 8070/3 Squamous cell carcinoma, NOS 8070/6 Squamous cell carcinoma, metastatic, NOS 8071/2 Differentiated intraepithelial neoplasia 8071/3 Squamous cell carcinoma, keratinizing, NOS 8072/0 Large cell acanthoma 8072/3 Squamous cell carcinoma, large cell, nonkeratinizing, NOS 8073/3 Squamous cell carcinoma, small cell, nonkeratinizing 8074/3 Squamous cell carcinoma, spindle cell 8075/3 Squamous cell carcinoma, adenoid 8076/2 Squamous cell carcinoma in situ with questionable stromal invasion 8076/3 Squamous cell carcinoma, microinvasive 8077/0 Squamous intraepithelial neoplasia, low grade 8077/2 Squamous intraepithelial neoplasia, high grade 8078/3 Squamous cell carcinoma with horn formation 8080/2 Queyrat erythroplasia 8081/2 Bowen disease 8082/3 Lymphoepithelial carcinoma 8083/3 Basaloid squamous cell carcinoma 8084/0 Clear cell acanthoma 8084/3 Squamous cell carcinoma, clear cell type 8085/3 Squamous cell carcinoma, HPV-positive 8086/3 Squamous cell carcinoma, HPV-negative 8090/1 Basal cell tumour 8090/3 Basal cell carcinoma, NOS 8091/3 Superficial basal cell carcinoma 8092/3 Infiltrating basal cell carcinoma, NOS 8093/3 Basal cell carcinoma, fibroepithelial 8094/3 Basosquamous carcinoma 8095/3 Metatypical carcinoma 8096/0 Intraepidermal epithelioma of Jadassohn 8097/3 Basal cell carcinoma, nodular 8098/3 Adenoid basal carcinoma 8100/0 Trichoepithelioma 8100/3 Trichoblastic carcinoma 8101/0 Trichofolliculoma 8102/0 Trichilemmoma 8102/3 Trichilemmocarcinoma 8103/0 Pilar tumour 8103/1 Proliferating trichilemmal cyst 8104/0 Pilar sheath acanthoma 8110/0 Pilomatricoma, NOS 8110/3 Pilomatrical carcinoma 8120/0 Urothelial papilloma, NOS 8120/2 Urothelial carcinoma in situ 8120/3 Transitional cell carcinoma, NOS 8121/0 Sinonasal papilloma, exophytic 8121/1 Sinonasal papilloma, inverted 8121/3 Schneiderian carcinoma 8122/3 Urothelial carcinoma, sarcomatoid 8123/3 Basaloid carcinoma 8124/3 Cloacogenic carcinoma 8130/1 Papillary urothelial neoplasm of low malignant potential 8130/2 Papillary urothelial carcinoma, non-invasive 8130/3 Papillary urothelial carcinoma 8131/3 Urothelial carcinoma, micropapillary 8140/0 Adenoma, NOS 8140/1 Atypical adenoma 8140/2 Adenocarcinoma in situ, NOS 8140/3 Adenocarcinoma, NOS 8140/6 Adenocarcinoma, metastatic, NOS 8141/3 Scirrhous adenocarcinoma 8142/3 Linitis plastica 8143/3 Superficial spreading adenocarcinoma 8144/0 Adenoma, intestinal type 8144/3 Adenocarcinoma, intestinal type 8145/3 Carcinoma, diffuse type 8146/0 Monomorphic adenoma 8147/0 Basal cell adenoma 8147/3 Basal cell adenocarcinoma 8148/0 Glandular intraepithelial neoplasia, low grade 8148/2 Glandular intraepithelial neoplasia, high grade 8149/0 Canalicular adenoma 8150/0 Pancreatic neuroendocrine microadenoma 8150/3 Pancreatic neuroendocrine tumour, nonfunctioning 8151/3 Insulinoma, NOS 8152/3 Glucagonoma 8153/3 Gastrinoma 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN) 8155/3 Vipoma 8156/3 Somatostatinoma 8158/3 ACTH-producing tumour 8160/0 Bile duct adenoma 8160/3 Cholangiocarcinoma 8161/0 Bile duct cystadenoma 8161/3 Bile duct cystadenocarcinoma 8162/3 Perihilar cholangiocarcinoma 8163/0 Pancreatobiliary neoplasm, non-invasive 8163/2 Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia 8163/3 Pancreatobiliary-type carcinoma 8170/0 Liver cell adenoma 8170/3 Hepatocellular carcinoma, NOS 8171/3 Hepatocellular carcinoma, fibrolamellar 8172/3 Hepatocellular carcinoma, scirrhous 8173/3 Hepatocellular carcinoma, spindle cell variant 8174/3 Hepatocellular carcinoma, clear cell type 8175/3 Hepatocellular carcinoma, pleomorphic type 8180/3 Combined hepatocellular carcinoma and cholangiocarcinoma 8190/0 Trabecular adenoma 8190/3 Trabecular adenocarcinoma 8191/0 Embryonal adenoma 8200/0 Eccrine dermal cylindroma 8200/3 Adenoid cystic carcinoma 8201/2 Cribriform carcinoma in situ 8201/3 Cribriform carcinoma, NOS 8202/0 Microcystic adenoma 8204/0 Lactating adenoma 8210/0 Adenomatous polyp, NOS 8210/2 Adenocarcinoma in situ in adenomatous polyp 8210/3 Adenocarcinoma in adenomatous polyp 8211/0 Tubular adenoma, NOS 8211/3 Tubular adenocarcinoma 8212/0 Flat adenoma 8213/0 Serrated adenoma 8213/3 Serrated adenocarcinoma 8214/3 Parietal cell carcinoma 8215/3 Adenocarcinoma of anal glands 8220/0 Adenomatous polyposis coli 8220/3 Adenocarcinoma in adenomatous polyposis coli 8221/0 Multiple adenomatous polyps 8221/3 Adenocarcinoma in multiple adenomatous polyps 8230/2 Ductal carcinoma in situ, solid type 8230/3 Solid carcinoma, NOS 8231/3 Carcinoma simplex 8240/3 Neuroendocrine tumour, NOS 8241/3 Enterochromaffin cell carcinoid 8242/3 Enterochromaffin-like cell tumour 8243/3 Goblet cell carcinoid 8244/3 Mixed adenoneuroendocrine carcinoma 8245/1 Tubular carcinoid 8245/3 Adenocarcinoid tumour 8246/3 Neuroendocrine carcinoma, NOS 8247/3 Merkel cell carcinoma 8248/1 Apudoma 8249/3 Neuroendocrine tumour, grade 2 8250/0 Atypical adenomatous hyperplasia 8250/1 Pulmonary adenomatosis 8250/2 Adenocarcinoma in situ of lung, non-mucinous 8250/3 Lepidic adenocarcinoma 8251/0 Alveolar adenoma 8251/3 Alveolar adenocarcinoma 8252/3 Bronchiolo-alveolar carcinoma, non-mucinous 8253/2 Adenocarcinoma in situ of lung, mucinous 8253/3 Adenocarcinoma of lung, mucinous 8254/3 Adenocarcinoma of lung, mixed mucinous and non-mucinous 8255/3 Adenocarcinoma with mixed subtypes 8256/3 Minimally invasive adenocarcinoma, Non-mucinous 8257/3 Minimally invasive adenocarcinoma, Mucinous 8260/0 Papillary adenoma, NOS 8260/1 Aggressive papillary tumour 8260/3 Papillary adenocarcinoma, NOS 8261/0 Villous adenoma, NOS 8261/2 Adenocarcinoma in situ in villous adenoma 8261/3 Adenocarcinoma in villous adenoma 8262/3 Villous adenocarcinoma 8263/0 Tubulovillous adenoma, NOS 8263/2 Adenocarcinoma in situ in tubulovillous adenoma 8263/3 Adenocarcinoma in tubulovillous adenoma 8264/0 Papillomatosis, glandular 8265/3 Micropapillary carcinoma, NOS 8270/0 Chromophobe adenoma 8270/3 Chromophobe carcinoma 8271/0 Lactotroph adenoma 8272/0 Pituitary adenoma, NOS 8272/3 Pituitary carcinoma, NOS 8273/3 Pituitary blastoma 8280/0 Acidophil adenoma 8280/3 Acidophil carcinoma 8281/0 Mixed acidophil-basophil adenoma 8281/3 Mixed acidophil-basophil carcinoma 8290/0 Oxyphilic adenoma 8290/3 Oxyphilic adenocarcinoma 8300/0 Basophil adenoma 8300/3 Basophil carcinoma 8310/0 Clear cell adenoma 8310/3 Clear cell adenocarcinoma, NOS 8311/1 Hypernephroid tumour 8311/3 Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma 8312/3 Renal cell carcinoma, NOS 8313/0 Clear cell adenofibroma 8313/1 Clear cell borderline tumour 8313/3 Clear cell adenocarcinofibroma 8314/3 Lipid-rich carcinoma 8315/3 Glycogen-rich carcinoma 8316/1 Multilocular cystic renal neoplasm of low malignant potential 8316/3 Cyst-associated renal cell carcinoma 8317/3 Renal cell carcinoma, chromophobe type 8318/3 Renal cell carcinoma, sarcomatoid 8319/3 Collecting duct carcinoma 8320/3 Granular cell carcinoma 8321/0 Chief cell adenoma 8322/0 Water-clear cell adenoma 8322/3 Water-clear cell adenocarcinoma 8323/0 Mixed cell adenoma 8323/1 Clear cell papillary renal cell carcinoma 8323/3 Mixed cell adenocarcinoma 8324/0 Lipoadenoma 8325/0 Metanephric adenoma 8330/0 Follicular adenoma 8330/1 Atypical follicular adenoma 8330/3 Follicular carcinoma, NOS 8331/3 Follicular adenocarcinoma, well differentiated 8332/3 Follicular adenocarcinoma, trabecular 8333/0 Microfollicular adenoma, NOS 8333/3 Fetal adenocarcinoma 8334/0 Macrofollicular adenoma 8335/1 Follicular tumour of uncertain malignant potential 8335/3 Follicular carcinoma, minimally invasive 8336/1 Hyalinizing trabecular tumour 8337/3 Poorly differentiated thyroid carcinoma 8339/3 Follicular carcinoma, encapsulated, angioinvasive 8340/3 Papillary carcinoma, follicular variant 8341/3 Papillary microcarcinoma 8342/3 Papillary carcinoma, oncocytic variant 8343/3 Papillary carcinoma, encapsulated, of thyroid 8344/3 Papillary carcinoma, columnar cell 8345/3 Medullary thyroid carcinoma 8346/3 Mixed medullary-follicular carcinoma 8347/3 Mixed medullary-papillary carcinoma 8348/1 Well differentiated tumour of uncertain malignant potential 8349/1 Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) 8350/3 Nonencapsulated sclerosing carcinoma 8360/1 Multiple endocrine adenomas 8361/0 Juxtaglomerular tumour 8370/0 Adrenal cortical adenoma, NOS 8370/3 Adrenal cortical carcinoma 8371/0 Adrenal cortical adenoma, compact cell 8372/0 Adrenal cortical adenoma, pigmented 8373/0 Adrenal cortical adenoma, clear cell 8374/0 Adrenal cortical adenoma, glomerulosa cell 8375/0 Adrenal cortical adenoma, mixed cell 8380/0 Endometrioid adenoma, NOS 8380/1 Endometrioid adenoma, borderline malignancy 8380/2 Endometrioid intraepithelial neoplasia 8380/3 Endometrioid adenocarcinoma, NOS 8381/0 Endometrioid adenofibroma, NOS 8381/1 Endometrioid adenofibroma, borderline malignancy 8381/3 Endometrioid adenofibroma, malignant 8382/3 Endometrioid adenocarcinoma, secretory variant 8383/3 Endometrioid adenocarcinoma, ciliated cell variant 8384/3 Adenocarcinoma, endocervical type 8390/0 Skin appendage adenoma 8390/3 Adnexal adenocarcinoma, NOS 8391/0 Follicular fibroma 8392/0 Syringofibroadenoma 8400/0 Sweat gland adenoma 8400/1 Sweat gland tumour, NOS 8400/3 Sweat gland adenocarcinoma 8401/0 Apocrine adenoma 8401/3 Apocrine adenocarcinoma 8402/0 Hidradenoma, NOS 8402/3 Hidradenocarcinoma 8403/0 Spiradenoma, NOS 8403/3 Malignant eccrine spiradenoma 8404/0 Hidrocystoma 8405/0 Papillary hidradenoma 8406/0 Syringocystadenoma papilliferum 8406/3 Syringocystadenocarcinoma papilliferum 8407/0 Syringoma, NOS 8407/3 Microcystic adnexal carcinoma 8408/0 Eccrine papillary adenoma 8409/0 Poroma, NOS 8409/2 Porocarcinoma in situ 8409/3 Porocarcinoma, NOS 8410/0 Sebaceoma 8410/3 Sebaceous carcinoma 8413/3 Eccrine adenocarcinoma 8420/0 Ceruminous adenoma 8420/3 Ceruminous adenocarcinoma 8430/1 Mucoepidermoid tumour 8430/3 Mucoepidermoid carcinoma 8440/0 Cystadenoma, NOS 8440/3 Cystadenocarcinoma, NOS 8441/0 Serous cystadenoma, NOS 8441/2 Serous intraepithelial carcinoma 8441/3 Serous carcinoma, NOS 8443/0 Clear cell cystadenoma 8450/0 Papillary cystadenoma, NOS 8450/3 Papillary cystadenocarcinoma, NOS 8451/1 Papillary cystadenoma, borderline malignancy 8452/1 Solid pseudopapillary tumour of ovary 8452/3 Solid pseudopapillary neoplasm of pancreas 8453/0 Intraductal papillary-mucinous adenoma 8453/2 Intraductal papillary mucinous neoplasm with high grade dysplasia 8453/3 Intraductal papillary mucinous neoplasm with an associated invasive carcinoma 8454/0 Cystic tumour of atrio-ventricular node 8460/2 Serous borderline tumour, micropapillary variant 8460/3 Low grade serous carcinoma 8461/0 Serous surface papilloma 8461/3 High grade serous carcinoma 8470/0 Mucinous cystadenoma, NOS 8470/2 Mucinous cystic neoplasm with high-grade dysplasia 8470/3 Mucinous cystadenocarcinoma, NOS 8472/1 Mucinous cystic tumour of borderline malignancy 8474/0 Seromucinous cystadenoma 8474/1 Seromucinous borderline tumour 8474/3 Seromucinous carcinoma 8480/0 Mucinous adenoma 8480/1 Low grade appendiceal mucinous neoplasm 8480/3 Mucinous adenocarcinoma 8480/6 Pseudomyxoma peritonei 8481/3 Mucin-producing adenocarcinoma 8482/3 Mucinous carcinoma, gastric type 8490/3 Signet ring cell carcinoma 8490/6 Metastatic signet ring cell carcinoma 8500/2 Intraductal carcinoma, noninfiltrating, NOS 8500/3 Infiltrating duct carcinoma, NOS 8501/2 Comedocarcinoma, noninfiltrating 8501/3 Comedocarcinoma, NOS 8502/3 Secretory carcinoma 8503/0 Intraductal papilloma 8503/2 Noninfiltrating intraductal papillary adenocarcinoma 8503/3 Intraductal papillary adenocarcinoma with invasion 8504/0 Intracystic papillary adenoma 8504/2 Noninfiltrating intracystic carcinoma 8504/3 Encapsulated papillary carcinoma with invasion 8505/0 Intraductal papillomatosis, NOS 8506/0 Adenoma of nipple 8507/2 Intraductal micropapillary carcinoma 8507/3 Invasive micropapillary carcinoma of breast 8508/3 Cystic hypersecretory carcinoma 8509/2 Solid papillary carcinoma in situ 8509/3 Solid papillary carcinoma with invasion 8510/3 Medullary carcinoma, NOS 8512/3 Medullary carcinoma with lymphoid stroma 8513/3 Atypical medullary carcinoma 8514/3 Duct carcinoma, desmoplastic type 8519/2 Lobular carcinoma in situ, pleomorphic 8520/2 Lobular carcinoma in situ, NOS 8520/3 Lobular carcinoma, NOS 8521/3 Infiltrating ductular carcinoma 8522/2 Intraductal carcinoma and lobular carcinoma in situ 8522/3 Infiltrating duct and lobular carcinoma 8523/3 Infiltrating duct mixed with other types of carcinoma 8524/3 Infiltrating lobular mixed with other types of carcinoma 8525/3 Polymorphous adenocarcinoma 8530/3 Inflammatory carcinoma 8540/3 Paget disease, mammary 8541/3 Paget disease and infiltrating duct carcinoma of breast 8542/3 Paget disease, extramammary 8543/3 Paget disease and intraductal carcinoma of breast 8550/0 Acinar cell adenoma 8550/1 Acinar cell tumour 8550/3 Acinar cell carcinoma 8551/3 Acinar cell cystadenocarcinoma 8552/3 Mixed acinar-ductal carcinoma 8560/0 Mixed squamous cell and glandular papilloma 8560/3 Adenosquamous carcinoma 8561/0 Adenolymphoma 8562/3 Epithelial-myoepithelial carcinoma 8563/0 Lymphadenoma 8570/3 Adenocarcinoma with squamous metaplasia 8571/3 Adenocarcinoma with cartilaginous and osseous metaplasia 8572/3 Adenocarcinoma with spindle cell metaplasia 8573/3 Adenocarcinoma with apocrine metaplasia 8574/3 Adenocarcinoma with neuroendocrine differentiation 8575/3 Metaplastic carcinoma, NOS 8576/3 Hepatoid adenocarcinoma 8580/0 Microscopic thymoma 8580/1 Micronodular thymoma with lymphoid stroma 8580/3 Thymoma, NOS 8581/3 Thymoma, type A 8582/3 Thymoma, type AB 8583/3 Thymoma, type B1 8584/3 Thymoma, type B2 8585/3 Thymoma, type B3 8586/3 Thymic carcinoma, NOS 8587/0 Ectopic hamartomatous thymoma 8588/3 Spindle epithelial tumour with thymus-like element 8589/3 Intrathyroid thymic carcinoma 8590/0 Sex cord-stromal tumour, benign 8590/1 Sex cord-gonadal stromal tumour, NOS 8591/1 Sex cord-gonadal stromal tumour, incompletely differentiated 8592/1 Sex cord-gonadal stromal tumour, mixed forms 8593/1 Stromal tumour with minor sex cord elements 8594/1 Mixed germ cell-sex cord-stromal tumour, NOS 8600/0 Thecoma, NOS 8600/3 Thecoma, malignant 8601/0 Thecoma, luteinized 8602/0 Sclerosing stromal tumour 8610/0 Luteoma, NOS 8620/1 Adult granulosa cell tumour of testis 8620/3 Adult granulosa cell tumour of ovary 8621/1 Granulosa cell-theca cell tumour 8622/0 Granulosa cell tumour of the testis, juvenile 8622/1 Granulosa cell tumour, juvenile 8623/1 Sex cord tumour with annular tubules 8630/0 Androblastoma, benign 8630/1 Androblastoma, NOS 8630/3 Androblastoma, malignant 8631/0 Sertoli-Leydig cell tumour, well differentiated 8631/1 Sertoli-Leydig cell tumour of intermediate differentiation 8631/3 Sertoli-Leydig cell tumour, poorly differentiated 8632/1 Gynandroblastoma 8633/1 Sertoli-Leydig cell tumour, retiform 8634/1 Sertoli-Leydig cell tumour, intermediate differentiation, with heterologous elements 8634/3 Sertoli-Leydig cell tumour, poorly differentiated, with heterologous elements 8640/1 Sertoli cell tumour, NOS 8640/3 Sertoli cell carcinoma 8641/0 Sertoli cell tumour with lipid storage 8642/1 Large cell calcifying Sertoli cell tumour 8643/1 Intratubular large cell hyalinizing Sertoli cell neoplasia 8650/0 Leydig cell tumour of the ovary, NOS 8650/1 Leydig cell tumour of the testis, NOS 8650/3 Leydig cell tumour, malignant 8660/0 Hilus cell tumour 8670/0 Lipid cell tumour of ovary 8670/3 Steroid cell tumour, malignant 8671/0 Adrenal rest tumour 8680/3 Paraganglioma, NOS 8681/3 Sympathetic paraganglioma 8682/3 Parasympathetic paraganglioma 8683/0 Gangliocytic paraganglioma 8690/3 Middle ear paraganglioma 8691/3 Aortic body tumour 8692/3 Carotid body paraganglioma 8693/3 Extra-adrenal paraganglioma 8700/3 Pheochromocytoma, NOS 8710/3 Glomangiosarcoma 8711/0 Glomus tumour, NOS 8711/1 Glomangiomatosis 8711/3 Glomus tumour, malignant 8712/0 Glomangioma 8713/0 Glomangiomyoma 8714/0 Perivascular epithelioid tumour, benign 8714/3 Perivascular epithelioid tumour, malignant 8720/0 Pigmented naevus, NOS 8720/2 Melanoma in situ 8720/3 Malignant melanoma, NOS 8721/3 Nodular melanoma 8722/0 Balloon cell naevus 8722/3 Balloon cell melanoma 8723/0 Halo naevus 8723/3 Malignant melanoma, regressing 8725/0 Neuronevus 8726/0 Magnocellular naevus 8727/0 Dysplastic naevus 8728/0 Meningeal melanocytosis 8728/1 Meningeal melanocytoma 8728/3 Meningeal melanomatosis 8730/0 Nonpigmented naevus 8730/3 Amelanotic melanoma 8740/0 Junctional naevus, NOS 8740/3 Malignant melanoma in junctional naevus 8741/2 Precancerous melanosis, NOS 8741/3 Malignant melanoma in precancerous melanosis 8742/0 Lentiginous melanocytic naevus 8742/2 Lentigo maligna 8742/3 Lentigo maligna melanoma 8743/3 Low cumulative sun damage melanoma 8744/0 Acral naevus 8744/3 Acral melanoma 8745/3 Desmoplastic melanoma, NOS 8746/3 Mucosal lentiginous melanoma 8750/0 Dermal naevus 8760/0 Compound naevus 8761/0 Congenital melanocytic naevus, NOS 8761/1 Giant pigmented naevus, NOS 8761/3 Malignant melanoma arising in giant congenital naevus 8762/1 Proliferative dermal lesion in congenital naevus 8770/0 Epithelioid and spindle cell naevus 8770/3 Malignant Spitz tumour 8771/0 Epithelioid cell naevus 8771/3 Epithelioid cell melanoma 8772/0 Spindle cell naevus, NOS 8772/3 Spindle cell melanoma, NOS 8773/3 Spindle cell melanoma, type A 8774/3 Spindle cell melanoma, type B 8780/0 Blue nevus, NOS 8780/1 Pigmented epithelioid melanocytoma 8780/3 Blue naevus, malignant 8790/0 Cellular blue naevus 8800/0 Soft tissue tumour, benign 8800/3 Sarcoma, NOS 8800/9 Sarcomatosis, NOS 8801/3 Spindle cell sarcoma 8802/1 Pleomorphic hyalinizing angiectatic tumour 8802/3 Giant cell sarcoma 8803/3 Small cell sarcoma 8804/3 Epithelioid sarcoma 8805/3 Undifferentiated sarcoma 8806/3 Desmoplastic small round cell tumour 8810/0 Fibroma, NOS 8810/1 Cellular fibroma 8810/3 Fibrosarcoma, NOS 8811/0 Fibromyxoma 8811/1 Myxoinflammatory fibroblastic sarcoma 8811/3 Myxofibrosarcoma 8812/0 Periosteal fibroma 8812/3 Periosteal fibrosarcoma 8813/0 Fibroma of tendon sheath 8813/1 Palmar/plantar type fibromatosis 8813/3 Fascial fibrosarcoma 8814/3 Infantile fibrosarcoma 8815/0 Solitary fibrous tumour/Haemangiopericytoma, grade 1 8815/1 Solitary fibrous tumour, NOS 8815/3 Solitary fibrous tumour, malignant 8816/0 Calcifying aponeurotic fibroma 8817/0 Calcifying fibrous tumour 8818/0 Fibrous dysplasia 8820/0 Elastofibroma 8821/1 Aggressive fibromatosis 8822/1 Abdominal fibromatosis 8823/0 Sclerotic fibroma 8823/1 Desmoplastic fibroma 8824/0 Myofibroma 8824/1 Myofibromatosis 8825/0 Myofibroblastoma 8825/1 Myofibroblastic tumour, NOS 8825/3 Myofibroblastic sarcoma 8826/0 Angiomyofibroblastoma 8827/1 Myofibroblastic tumour, peribronchial 8828/0 Nodular fasciitis 8830/0 Benign fibrous histiocytoma 8830/1 Atypical fibrous histiocytoma 8830/3 Malignant fibrous histiocytoma 8831/0 Histiocytoma, NOS 8832/0 Dermatofibroma, NOS 8832/1 Dermatofibrosarcoma protuberans, NOS 8832/3 Dermatofibrosarcoma protuberans, fibrosarcomatous 8833/1 Pigmented dermatofibrosarcoma protuberans 8834/1 Giant cell fibroblastoma 8835/1 Plexiform fibrohistiocytic tumour 8836/1 Angiomatoid fibrous histiocytoma 8840/0 Myxoma, NOS 8840/3 Myxosarcoma 8841/0 Angiomyxoma 8842/0 Ossifying fibromyxoid tumour 8842/3 Ossifying fibromyxoid tumour, malignant 8850/0 Lipoma, NOS 8850/1 Atypical lipomatous tumour 8850/3 Liposarcoma, NOS 8851/0 Fibrolipoma 8851/1 Lipofibromatosis 8851/3 Liposarcoma, well differentiated 8852/0 Fibromyxolipoma 8852/3 Myxoid liposarcoma 8854/0 Pleomorphic lipoma 8854/3 Pleomorphic liposarcoma 8855/3 Mixed liposarcoma 8856/0 Intramuscular lipoma 8857/0 Spindle cell lipoma 8857/3 Fibroblastic liposarcoma 8858/3 Dedifferentiated liposarcoma 8860/0 Angiomyolipoma 8860/1 Angiomyolipoma, Epithelioid 8861/0 Angiolipoma, NOS 8862/0 Chondroid lipoma 8870/0 Myelolipoma 8880/0 Hibernoma 8881/0 Lipoblastomatosis 8890/0 Leiomyoma, NOS 8890/1 Leiomyomatosis, NOS 8890/3 Leiomyosarcoma, NOS 8891/0 Epithelioid leiomyoma 8891/3 Epithelioid leiomyosarcoma 8892/0 Cellular leiomyoma 8893/0 Bizarre leiomyoma 8894/0 Angiomyoma 8894/3 Angiomyosarcoma 8895/0 Myoma 8895/3 Myosarcoma 8896/0 Myxoid leiomyoma 8896/3 Myxoid leiomyosarcoma 8897/1 Smooth muscle tumour of uncertain malignant potential 8898/1 Metastasizing leiomyoma 8900/0 Rhabdomyoma, NOS 8900/3 Rhabdomyosarcoma, NOS 8901/3 Pleomorphic rhabdomyosarcoma, adult type 8902/3 Mixed type rhabdomyosarcoma 8903/0 Fetal rhabdomyoma 8904/0 Adult cellular rhabdomyoma 8905/0 Genital rhabdomyoma 8910/3 Embryonal rhabdomyosarcoma, NOS 8912/3 Spindle cell rhabdomyosarcoma 8920/3 Alveolar rhabdomyosarcoma 8921/3 Ectomesenchymoma 8930/0 Endometrial stromal nodule 8930/3 Endometrial stromal sarcoma, NOS 8931/3 Endometrial stromal sarcoma, low grade 8932/0 Adenomyoma 8933/3 Adenosarcoma 8934/3 Carcinofibroma 8935/0 Stromal tumour, benign 8935/1 Stromal tumour, NOS 8935/3 Stromal sarcoma, NOS 8936/3 Gastrointestinal stromal tumour 8940/0 Pleomorphic adenoma 8940/3 Mixed tumour, malignant, NOS 8941/3 Carcinoma ex pleomorphic adenoma 8950/3 Mullerian mixed tumour 8951/3 Mesodermal mixed tumour 8959/0 Benign cystic nephroma 8959/1 Cystic partially differentiated nephroblastoma 8959/3 Malignant cystic nephroma 8960/1 Mesoblastic nephroma 8960/3 Nephroblastoma, NOS 8963/3 Rhabdoid tumour, NOS 8964/3 Clear cell sarcoma of kidney 8966/0 Renomedullary interstitial cell tumour 8967/0 Ossifying renal tumour 8970/3 Hepatoblastoma 8971/3 Pancreatoblastoma 8972/3 Pulmonary blastoma 8973/3 Pleuropulmonary blastoma 8974/1 Sialoblastoma 8975/1 Calcifying nested stromal-epithelial tumour 8980/3 Carcinosarcoma, NOS 8981/3 Carcinosarcoma, embryonal 8982/0 Myoepithelioma 8982/3 Myoepithelial carcinoma 8983/0 Adenomyoepithelioma, NOS 8983/3 Adenomyoepithelioma with carcinoma 8990/0 Mesenchymoma, benign 8990/1 Mesenchymoma, NOS 8990/3 Mesenchymoma, malignant 8991/3 Embryonal sarcoma 8992/0 Pulmonary hamartoma 9000/0 Brenner tumour, NOS 9000/1 Brenner tumour, borderline malignancy 9000/3 Brenner tumour, malignant 9010/0 Fibroadenoma, NOS 9011/0 Intracanalicular fibroadenoma 9012/0 Pericanalicular fibroadenoma 9013/0 Adenofibroma, NOS 9014/0 Serous adenofibroma, NOS 9014/1 Serous adenofibroma of borderline malignancy 9014/3 Serous adenocarcinofibroma 9015/0 Mucinous adenofibroma, NOS 9015/1 Mucinous adenofibroma of borderline malignancy 9015/3 Mucinous adenocarcinofibroma 9016/0 Giant fibroadenoma 9020/0 Phyllodes tumour, benign 9020/1 Phyllodes tumour, borderline 9020/3 Phyllodes tumour, malignant 9030/0 Juvenile fibroadenoma 9040/0 Synovioma, benign 9040/3 Synovial sarcoma, NOS 9041/3 Synovial sarcoma, spindle cell 9042/3 Synovial sarcoma, epithelioid cell 9043/3 Synovial sarcoma, biphasic 9044/3 Clear cell sarcoma, NOS 9045/3 Biphenotypic sinonasal sarcoma 9050/0 Mesothelioma, benign 9050/3 Mesothelioma, malignant 9051/0 Fibrous mesothelioma, benign 9051/3 Fibrous mesothelioma, malignant 9052/0 Epithelioid mesothelioma, benign 9052/1 Well differentiated papillary mesothelioma of the pleura 9052/3 Epithelioid mesothelioma, malignant 9053/3 Mesothelioma, biphasic, malignant 9054/0 Adenomatoid tumour, NOS 9055/0 Peritoneal inclusion cysts 9060/3 Dysgerminoma 9061/3 Seminoma, NOS 9062/3 Seminoma, anaplastic 9063/3 Spermatocytic seminoma 9064/2 Intratubular malignant germ cells 9064/3 Germinoma 9065/3 Germ cell tumour, nonseminomatous 9070/3 Embryonal carcinoma, NOS 9071/3 Yolk sac tumour 9072/3 Polyembryoma 9073/1 Gonadoblastoma 9080/0 Teratoma, benign 9080/1 Teratoma, NOS 9080/3 Teratoma, malignant, NOS 9081/3 Teratocarcinoma 9082/3 Malignant teratoma, undifferentiated 9083/3 Malignant teratoma, intermediate 9084/0 Dermoid cyst, NOS 9084/3 Teratoma with malignant transformation 9085/3 Mixed germ cell tumour 9086/3 Germ cell tumour with associated haematological malignancy 9090/0 Struma ovarii, NOS 9090/3 Struma ovarii, malignant 9091/1 Strumal carcinoid 9100/0 Hydatidiform mole, NOS 9100/1 Invasive hydatidiform mole 9100/3 Choriocarcinoma, NOS 9101/3 Choriocarcinoma combined with other germ cell elements 9102/3 Malignant teratoma, trophoblastic 9103/0 Partial hydatidiform mole 9104/1 Placental site trophoblastic tumour 9105/3 Trophoblastic tumour, epithelioid 9110/0 Adenoma of rete ovarii 9110/1 Wolffian tumour 9110/3 Mesonephroma, malignant 9120/0 Haemangioma, NOS 9120/3 Hemangiosarcoma 9121/0 Cavernous haemangioma 9122/0 Venous haemangioma 9123/0 Racemose haemangioma 9124/3 Kupffer cell sarcoma 9125/0 Epithelioid haemangioma 9126/0 Atypical vascular lesion 9130/0 Haemangioendothelioma, benign 9130/1 Haemangioendothelioma, NOS 9130/3 Haemangioendothelioma, malignant 9131/0 Capillary haemangioma 9132/0 Intramuscular haemangioma 9133/3 Epithelioid haemangioendothelioma, NOS 9135/1 Papillary intralymphatic angioendothelioma 9136/1 Spindle cell haemangioendothelioma 9137/0 Myointimoma 9137/3 Intimal sarcoma 9138/1 Pseudomyogenic (epithelioid sarcoma-like) haemangioendothelioma 9140/3 Kaposi sarcoma 9141/0 Angiokeratoma 9142/0 Verrucous keratotic haemangioma 9160/0 Angiofibroma, NOS 9161/0 Acquired tufted haemangioma 9161/1 Haemangioblastoma 9170/0 Lymphangioma, NOS 9170/3 Lymphangiosarcoma 9171/0 Capillary lymphangioma 9172/0 Cavernous lymphangioma 9173/0 Cystic lymphangioma 9174/0 Lymphangiomyoma 9174/1 Lymphangiomyomatosis 9175/0 Haemolymphangioma 9180/0 Osteoma, NOS 9180/3 Osteosarcoma, NOS 9181/3 Chondroblastic osteosarcoma 9182/3 Fibroblastic osteosarcoma 9183/3 Telangiectatic osteosarcoma 9184/3 Osteosarcoma in Paget disease of bone 9185/3 Small cell osteosarcoma 9186/3 Central osteosarcoma 9187/3 Low grade central osteosarcoma 9191/0 Osteoid osteoma, NOS 9192/3 Parosteal osteosarcoma 9193/3 Periosteal osteosarcoma 9194/3 High grade surface osteosarcoma 9195/3 Intracortical osteosarcoma 9200/0 Osteoblastoma, NOS 9200/1 Aggressive osteoblastoma 9210/0 Osteochondroma 9210/1 Osteochondromatosis, NOS 9211/0 Osteochondromyxoma 9212/0 Bizarre parosteal osteochondromatous proliferation 9213/0 Subungual exostosis 9220/0 Chondroma, NOS 9220/1 Chondromatosis, NOS 9220/3 Chondrosarcoma, NOS 9221/0 Periosteal chondroma 9221/3 Periosteal chondrosarcoma 9222/1 Atypical cartilaginous tumour 9230/1 Chondroblastoma, NOS 9230/3 Chondroblastoma, malignant 9231/3 Myxoid chondrosarcoma 9240/3 Mesenchymal chondrosarcoma 9241/0 Chondromyxoid fibroma 9242/3 Clear cell chondrosarcoma 9243/3 Dedifferentiated chondrosarcoma 9250/1 Giant cell tumour of bone, NOS 9250/3 Giant cell tumour of bone, malignant 9251/1 Giant cell tumour of soft parts, NOS 9251/3 Malignant giant cell tumour of soft parts 9252/0 Tenosynovial giant cell tumour, NOS 9252/1 Tenosynovial giant cell tumour, diffuse 9252/3 Malignant tenosynovial giant cell tumour 9260/0 Aneurysmal bone cyst 9261/3 Adamantinoma of long bones 9262/0 Ossifying fibroma 9270/0 Odontogenic tumour, benign 9270/1 Odontogenic tumour, NOS 9270/3 Odontogenic tumour, malignant 9271/0 Ameloblastic fibrodentinoma 9272/0 Cementoma, NOS 9273/0 Cementoblastoma, benign 9274/0 Cemento-ossifying fibroma 9275/0 Gigantiform cementoma 9280/0 Odontoma, NOS 9281/0 Compound odontoma 9282/0 Complex odontoma 9290/0 Ameloblastic fibro-odontoma 9290/3 Ameloblastic odontosarcoma 9300/0 Adenomatoid odontogenic tumour 9301/0 Calcifying odontogenic cyst 9302/0 Dentinogenic ghost cell tumour 9302/3 Ghost cell odontogenic carcinoma 9310/0 Ameloblastoma, NOS 9310/3 Ameloblastoma, metastasizing 9311/0 Odontoameloblastoma 9312/0 Squamous odontogenic tumour 9320/0 Odontogenic myxoma 9321/0 Odontogenic fibroma, NOS 9322/0 Peripheral odontogenic fibroma 9330/0 Ameloblastic fibroma 9330/3 Ameloblastic fibrosarcoma 9340/0 Calcifying epithelial odontogenic tumour 9341/3 Clear cell odontogenic carcinoma 9342/3 Odontogenic carcinosarcoma 9350/1 Craniopharyngioma 9351/1 Craniopharyngioma, adamantinomatous 9352/1 Craniopharyngioma, papillary 9360/1 Pinealoma 9361/1 Pineocytoma 9362/3 Pineoblastoma 9363/0 Melanotic neuroectodermal tumour 9364/3 Ewing sarcoma 9365/3 Askin tumour 9370/0 Benign notochordal cell tumour 9370/3 Chordoma, NOS 9371/3 Chondroid chordoma 9372/3 Dedifferentiated chordoma 9373/0 Parachordoma 9380/3 Glioma, malignant 9381/3 Gliomatosis cerebri 9382/3 Oligoastrocytoma, NOS 9383/1 Subependymoma 9384/1 Subependymal giant cell astrocytoma 9385/3 Diffuse midline glioma, H3 K27M-mutant 9390/0 Choroid plexus papilloma, NOS 9390/1 Atypical choroid plexus papilloma 9390/3 Choroid plexus carcinoma 9391/1 Sellar ependymoma 9391/3 Ependymoma, NOS 9392/3 Ependymoma, anaplastic 9393/3 Papillary ependymoma 9394/1 Myxopapillary ependymoma 9395/3 Papillary tumour of the pineal region 9396/3 Ependymoma, RELA fusion-positive 9400/3 Astrocytoma, NOS 9401/3 Astrocytoma, anaplastic 9410/3 Protoplasmic astrocytoma 9411/3 Gemistocytic astrocytoma 9412/1 Desmoplastic infantile astrocytoma 9413/0 Dysembryoplastic neuroepithelial tumour 9420/3 Fibrillary astrocytoma 9421/1 Pilocytic astrocytoma 9423/3 Polar spongioblastoma 9424/3 Pleomorphic xanthoastrocytoma 9425/3 Pilomyxoid astrocytoma 9430/3 Astroblastoma 9431/1 Angiocentric glioma 9432/1 Pituicytoma 9440/3 Glioblastoma, NOS 9441/3 Giant cell glioblastoma 9442/1 Gliofibroma 9442/3 Gliosarcoma 9444/1 Chordoid glioma 9445/3 Glioblastoma, IDH mutant 9450/3 Oligodendroglioma, NOS 9451/3 Oligodendroglioma, anaplastic 9460/3 Oligodendroblastoma 9470/3 Medulloblastoma, NOS 9471/3 Desmoplastic nodular medulloblastoma 9472/3 Medullomyoblastoma 9473/3 CNS embryonal tumour, NOS 9474/3 Large cell medulloblastoma 9475/3 Medulloblastoma, WNT-activated, NOS 9476/3 Medulloblastoma, SHH-activated and TP53-mutant 9477/3 Medulloblastoma, non-WNT/non-SHH 9478/3 Embryonal tumours with multilayered rosettes with C19MC alteration 9480/3 Cerebellar sarcoma, NOS 9490/0 Ganglioneuroma 9490/3 Ganglioneuroblastoma 9491/0 Ganglioneuromatosis 9492/0 Gangliocytoma 9493/0 Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) 9500/3 Neuroblastoma, NOS 9501/0 Medulloepithelioma, benign 9501/3 Medulloepithelioma, NOS 9502/0 Teratoid medulloepithelioma, benign 9502/3 Teratoid medulloepithelioma 9503/3 Neuroepithelioma, NOS 9504/3 Spongioneuroblastoma 9505/1 Ganglioglioma, NOS 9505/3 Ganglioglioma, anaplastic 9506/1 Central neurocytoma 9507/0 Pacinian tumour 9508/3 Atypical teratoid/rhabdoid tumour 9509/1 Papillary glioneuronal tumour 9510/0 Retinocytoma 9510/3 Retinoblastoma, NOS 9511/3 Retinoblastoma, differentiated 9512/3 Retinoblastoma, undifferentiated 9513/3 Retinoblastoma, diffuse 9514/1 Retinoblastoma, spontaneously regressed 9520/3 Olfactory neurogenic tumour 9521/3 Olfactory neurocytoma 9522/3 Olfactory neuroblastoma 9523/3 Olfactory neuroepithelioma 9530/0 Meningioma, NOS 9530/3 Meningioma, malignant 9531/0 Meningothelial meningioma 9532/0 Fibrous meningioma 9533/0 Psammomatous meningioma 9534/0 Angiomatous meningioma 9535/0 Haemangioblastic meningioma 9537/0 Transitional meningioma 9538/1 Clear cell meningioma 9538/3 Papillary meningioma 9539/1 Atypical meningioma 9539/3 Meningeal sarcomatosis 9540/0 Neurofibroma, NOS 9540/3 Malignant peripheral nerve sheath tumour 9541/0 Melanotic neurofibroma 9542/3 Malignant peripheral nerve sheath tumour, epithelioid 9550/0 Plexiform neurofibroma 9560/0 Schwannoma, NOS 9560/1 Melanotic schwannoma 9560/3 Neurilemoma, malignant 9561/3 Malignant peripheral nerve sheath tumour with rhabdomyoblastic differentiation 9562/0 Nerve sheath myxoma 9563/0 Nerve sheath tumour, NOS 9570/0 Neuroma, NOS 9571/0 Perineurioma, NOS 9571/3 Perineurioma, malignant 9580/0 Granular cell tumour, NOS 9580/3 Granular cell tumour, malignant 9581/3 Alveolar soft part sarcoma 9582/0 Granular cell tumour of the sellar region 9590/3 Malignant lymphoma, NOS 9591/1 Monoclonal B-cell lymphocytosis, NOS 9591/3 Malignant lymphoma, non-Hodgkin, NOS 9596/3 Composite Hodgkin and non-Hodgkin lymphoma 9597/3 Primary cutaneous follicle centre lymphoma 9650/3 Hodgkin lymphoma, NOS 9651/3 Hodgkin lymphoma, lymphocyte-rich 9652/3 Hodgkin lymphoma, mixed cellularity, NOS 9653/3 Hodgkin lymphoma, lymphocyte depletion, NOS 9654/3 Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis 9655/3 Hodgkin lymphoma, lymphocyte depletion, reticular 9659/3 Hodgkin lymphoma, nodular lymphocyte predominant 9661/3 Hodgkin granuloma 9662/3 Hodgkin sarcoma 9663/3 Hodgkin lymphoma, nodular sclerosis, NOS 9664/3 Hodgkin lymphoma, nodular sclerosis, cellular phase 9665/3 Hodgkin lymphoma, nodular sclerosis, grade 1 9667/3 Hodgkin lymphoma, nodular sclerosis, grade 2 9671/3 Lymphoplasmacytic lymphoma 9673/1 In situ mantle cell neoplasia 9673/3 Mantle cell lymphoma 9675/3 Malignant lymphoma, mixed small and large cell, diffuse 9678/3 Primary effusion lymphoma 9679/3 Mediastinal large B-cell lymphoma 9680/1 EBV positive mucocutaneous ulcer 9680/3 Diffuse large B-cell lymphoma, NOS 9684/3 Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS 9687/3 Burkitt lymphoma, NOS 9688/3 T-cell/histiocyte rich large B-cell lymphoma 9689/3 Splenic marginal zone B-cell lymphoma 9690/3 Follicular lymphoma, NOS 9691/3 Follicular lymphoma, grade 2 9695/1 In situ follicular neoplasia 9695/3 Follicular lymphoma, grade 1 9698/3 Follicular lymphoma, grade 3 9699/3 Marginal zone B-cell lymphoma, NOS 9700/3 Mycosis fungoides 9701/3 Sezary syndrome 9702/1 Indolent T-cell lymphoproliferative disorder of gastrointestinal tract 9702/3 Mature T-cell lymphoma, NOS 9705/3 Angioimmunoblastic T-cell lymphoma 9708/3 Subcutaneous panniculitis-like T-cell lymphoma 9709/1 Primary cutaneous CD4 positive small/medium T-cell lymphoproliferative disorder 9709/3 Cutaneous T-cell lymphoma, NOS 9712/3 Intravascular large B-cell lymphoma 9714/3 Anaplastic large cell lymphoma, T cell and Null cell type 9715/3 Anaplastic large cell lymphoma, ALK negative 9716/3 Hepatosplenic T-cell lymphoma 9717/3 Intestinal T-cell lymphoma 9718/1 Primary cutaneous CD30+ T-cell lymphoproliferative disorder 9718/3 Primary cutaneous anaplastic large cell lymphoma 9719/3 NK/T-cell lymphoma, nasal and nasal-type 9724/3 Systemic EBV positive T-cell lymphoproliferative disease of childhood 9725/1 Hydroa vacciniforme-like lymphoproliferative disorder 9726/3 Primary cutaneous gamma/delta T-cell lymphoma 9727/3 Precursor cell lymphoblastic lymphoma, NOS 9731/3 Plasmacytoma, NOS 9732/3 Plasma cell myeloma 9733/3 Plasma cell leukaemia 9734/3 Plasmacytoma, extramedullary 9735/3 Plasmablastic lymphoma 9737/3 ALK positive large B-cell lymphoma 9738/3 Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease 9740/1 Mastocytoma, NOS 9740/3 Mast cell sarcoma 9741/1 Indolent systemic mastocytosis 9741/3 Malignant mastocytosis 9742/3 Mast cell leukaemia 9749/3 Erdheim-Chester disease 9750/3 Malignant histiocytosis 9751/1 Langerhans cell histiocytosis 9751/3 Langerhans cell histiocytosis, disseminated 9755/3 Histiocytic sarcoma 9756/3 Langerhans cell sarcoma 9757/3 Interdigitating dendritic cell sarcoma 9758/3 Follicular dendritic cell sarcoma 9759/3 Fibroblastic reticular cell tumour 9760/3 Immunoproliferative disease, NOS 9761/1 IgM monoclonal gammopathy of undetermined significance 9761/3 Waldenstrom macroglobulinemia 9762/3 Heavy chain disease, NOS 9764/3 Immunoproliferative small intestinal disease 9765/1 Monoclonal gammopathy of undetermined significance 9766/1 Angiocentric immunoproliferative lesion 9766/3 Lymphomatoid granulomatosis, grade 3 9767/1 Angioimmunoblastic lymphadenopathy (AIL) 9768/1 T-gamma lymphoproliferative disease 9769/1 Immunoglobulin deposition disease 9800/3 Leukaemia, NOS 9801/3 Acute leukaemia, NOS 9805/3 Acute biphenotypic leukaemia 9806/3 Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1 9807/3 Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged 9808/3 Mixed phenotype acute leukaemia, B/myeloid, NOS 9809/3 Mixed phenotype acute leukaemia, T/myeloid, NOS 9811/3 B lymphoblastic leukaemia/lymphoma, NOS 9812/3 B lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 9813/3 B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged 9814/3 B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) 9815/3 B lymphoblastic leukaemia/lymphoma with hyperdiploidy 9816/3 B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL) 9817/3 B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH 9818/3 B lymphoblastic leukaemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) 9819/3 B lymphoblastic leukemia/lymphoma, BCR-ABL1-like 9820/3 Lymphoid leukaemia, NOS 9823/1 Monoclonal B-cell lymphocytosis, CLL type 9823/3 B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma 9827/3 Adult T-cell leukaemia/lymphoma (HTLV-1 positive) 9831/3 T-cell large granular lymphocytic leukaemia 9832/3 Prolymphocytic leukaemia, NOS 9833/3 Prolymphocytic leukaemia, B-cell type 9834/3 Prolymphocytic leukaemia, T-cell type 9835/3 Precursor cell lymphoblastic leukaemia, NOS 9837/3 Precursor T-cell lymphoblastic leukaemia 9840/3 Acute erythroid leukemia 9860/3 Myeloid leukaemia, NOS 9861/3 Acute myeloid leukaemia, NOS 9863/3 Chronic myeloid leukaemia, NOS 9865/3 Acute myeloid leukaemia with t(6;9)(p23;q34); DEK-NUP214 9866/3 Acute promyelocytic leukaemia, t(15;17)(q22;q11-12) 9867/3 Acute myelomonocytic leukaemia 9869/3 Acute myeloid leukaemia with inv(3)(q21;q26.2) or t(3.3)(q21;q26.2); RPN1-EVI1 9870/3 Acute basophilic leukaemia 9871/3 Acute myeloid leukaemia with abnormal marrow eosinophils 9872/3 Acute myeloid leukaemia, minimal differentiation 9873/3 Acute myeloid leukaemia without maturation 9874/3 Acute myeloid leukaemia with maturation 9875/3 Chronic myelogenous leukaemia, BCR/ABL positive 9876/3 Atypical chronic myeloid leukaemia, BCR/ABL negative 9877/3 Acute myeloid leukaemia with mutated NPM1 9878/3 Acute myeloid leukemia with biallelic mutation of CEBPA 9879/3 Acute myeloid leukemia with mutated RUNX1 9891/3 Acute monocytic leukaemia 9895/3 Acute myeloid leukaemia with myelodysplasia-related changes 9896/3 Acute myeloid leukaemia, t(8;21)(q22;q22) 9897/3 Acute myeloid leukaemia, 11q23 abnormalities 9898/1 Transient abnormal myelopoiesis 9898/3 Myeloid leukaemia associated with Down Syndrome 9910/3 Acute megakaryoblastic leukaemia 9911/3 Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 9912/3 Acute myeloid leukemia with BCR-ABL1 9920/3 Therapy related myeloid neoplasm 9930/3 Myeloid sarcoma 9931/3 Acute panmyelosis with myelofibrosis 9940/3 Hairy cell leukaemia 9945/3 Chronic myelomonocytic leukaemia, NOS 9946/3 Juvenile myelomonocytic leukaemia 9948/3 Aggressive NK-cell leukaemia 9950/3 Polycythaemia vera 9960/3 Myeloproliferative neoplasm, NOS 9961/3 Primary myelofibrosis 9962/3 Essential thrombocythemia 9963/3 Chronic neutrophilic leukaemia 9964/3 Chronic eosinophilic leukaemia 9965/3 Myeloid and lymphoid neoplasms with PDGFRA rearrangement 9966/3 Myeloid neoplasms with PDGFRB rearrangement 9967/3 Myeloid and lymphoid neoplasms with FGFR1 abnormalities 9968/3 Myeloid or lymphoid neoplasm with PCM1-JAK2 9970/1 Lymphoproliferative disorder, NOS 9971/1 Post transplant lymphoproliferative disorder, NOS 9975/3 Myeloproliferative neoplasm, unclassifiable 9982/3 Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia 9983/3 Myelodysplastic syndrome with excess blasts 9984/3 Refractory anaemia with excess blasts in transformation 9985/3 Myelodysplastic syndrome with multilineage dysplasia 9986/3 Myelodysplastic syndrome with isolated del (5q) 9987/3 Therapy-related myelodysplastic syndrome, NOS 9989/3 Myelodysplastic syndrome, NOS 9993/3 Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia 8408/3 Digital papillary adenocarcinoma 8442/1 Serous borderline tumour, NOS 9980/3 Myelodysplastic syndrome with single lineage dysplasia
The Value Set is used for coding the site (topography) and the histology (morphology) of neoplasms
Neoplasm, uncertain whether benign or malignant
Neoplasm, malignant, uncertain whether primary or metastatic
Tumour cells, uncertain whether benign or malignant
Large cell carcinoma with rhabdoid phenotype
Nuclear protein in testis (NUT) associated carcinoma
Carcinoma with osteoclast-like giant cells
Papillary squamous cell carcinoma, non-invasive
Squamous cell carcinoma, metastatic, NOS
Differentiated intraepithelial neoplasia
Squamous cell carcinoma, keratinizing, NOS
Squamous cell carcinoma, large cell, nonkeratinizing, NOS
Squamous cell carcinoma, small cell, nonkeratinizing
Squamous cell carcinoma in situ with questionable stromal invasion
Squamous intraepithelial neoplasia, low grade
Squamous intraepithelial neoplasia, high grade
Squamous cell carcinoma with horn formation
Squamous cell carcinoma, clear cell type
Papillary urothelial neoplasm of low malignant potential
Papillary urothelial carcinoma, non-invasive
Glandular intraepithelial neoplasia, low grade
Glandular intraepithelial neoplasia, high grade
Pancreatic neuroendocrine tumour, nonfunctioning
Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN)
Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia
Hepatocellular carcinoma, spindle cell variant
Hepatocellular carcinoma, clear cell type
Hepatocellular carcinoma, pleomorphic type
Combined hepatocellular carcinoma and cholangiocarcinoma
Adenocarcinoma in situ in adenomatous polyp
Adenocarcinoma in adenomatous polyposis coli
Adenocarcinoma in multiple adenomatous polyps
Adenocarcinoma in situ of lung, non-mucinous
Bronchiolo-alveolar carcinoma, non-mucinous
Adenocarcinoma in situ of lung, mucinous
Adenocarcinoma of lung, mixed mucinous and non-mucinous
Minimally invasive adenocarcinoma, Non-mucinous
Minimally invasive adenocarcinoma, Mucinous
Adenocarcinoma in situ in villous adenoma
Adenocarcinoma in situ in tubulovillous adenoma
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma
Multilocular cystic renal neoplasm of low malignant potential
Clear cell papillary renal cell carcinoma
Follicular adenocarcinoma, well differentiated
Follicular tumour of uncertain malignant potential
Follicular carcinoma, minimally invasive
Follicular carcinoma, encapsulated, angioinvasive
Papillary carcinoma, encapsulated, of thyroid
Well differentiated tumour of uncertain malignant potential
Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)
Adrenal cortical adenoma, glomerulosa cell
Endometrioid adenoma, borderline malignancy
Endometrioid adenofibroma, borderline malignancy
Endometrioid adenocarcinoma, secretory variant
Endometrioid adenocarcinoma, ciliated cell variant
Papillary cystadenoma, borderline malignancy
Solid pseudopapillary neoplasm of pancreas
Intraductal papillary mucinous neoplasm with high grade dysplasia
Intraductal papillary mucinous neoplasm with an associated invasive carcinoma
Serous borderline tumour, micropapillary variant
Mucinous cystic neoplasm with high-grade dysplasia
Mucinous cystic tumour of borderline malignancy
Intraductal carcinoma, noninfiltrating, NOS
Noninfiltrating intraductal papillary adenocarcinoma
Intraductal papillary adenocarcinoma with invasion
Encapsulated papillary carcinoma with invasion
Invasive micropapillary carcinoma of breast
Medullary carcinoma with lymphoid stroma
Intraductal carcinoma and lobular carcinoma in situ
Infiltrating duct mixed with other types of carcinoma
Infiltrating lobular mixed with other types of carcinoma
Paget disease and infiltrating duct carcinoma of breast
Paget disease and intraductal carcinoma of breast
Mixed squamous cell and glandular papilloma
Adenocarcinoma with cartilaginous and osseous metaplasia
Adenocarcinoma with spindle cell metaplasia
Adenocarcinoma with neuroendocrine differentiation
Micronodular thymoma with lymphoid stroma
Spindle epithelial tumour with thymus-like element
Sex cord-gonadal stromal tumour, incompletely differentiated
Sex cord-gonadal stromal tumour, mixed forms
Stromal tumour with minor sex cord elements
Mixed germ cell-sex cord-stromal tumour, NOS
Granulosa cell tumour of the testis, juvenile
Sertoli-Leydig cell tumour, well differentiated
Sertoli-Leydig cell tumour of intermediate differentiation
Sertoli-Leydig cell tumour, poorly differentiated
Sertoli-Leydig cell tumour, intermediate differentiation, with heterologous elements
Sertoli-Leydig cell tumour, poorly differentiated, with heterologous elements
Large cell calcifying Sertoli cell tumour
Intratubular large cell hyalinizing Sertoli cell neoplasia
Perivascular epithelioid tumour, malignant
Malignant melanoma in precancerous melanosis
Malignant melanoma arising in giant congenital naevus
Proliferative dermal lesion in congenital naevus
Pleomorphic hyalinizing angiectatic tumour
Solitary fibrous tumour/Haemangiopericytoma, grade 1
Dermatofibrosarcoma protuberans, fibrosarcomatous
Pigmented dermatofibrosarcoma protuberans
Smooth muscle tumour of uncertain malignant potential
Pleomorphic rhabdomyosarcoma, adult type
Cystic partially differentiated nephroblastoma
Calcifying nested stromal-epithelial tumour
Serous adenofibroma of borderline malignancy
Mucinous adenofibroma of borderline malignancy
Well differentiated papillary mesothelioma of the pleura
Germ cell tumour with associated haematological malignancy
Choriocarcinoma combined with other germ cell elements
Papillary intralymphatic angioendothelioma
Pseudomyogenic (epithelioid sarcoma-like) haemangioendothelioma
Bizarre parosteal osteochondromatous proliferation
Malignant giant cell tumour of soft parts
Malignant tenosynovial giant cell tumour
Calcifying epithelial odontogenic tumour
Medulloblastoma, SHH-activated and TP53-mutant
Embryonal tumours with multilayered rosettes with C19MC alteration
Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)
Malignant peripheral nerve sheath tumour
Malignant peripheral nerve sheath tumour, epithelioid
Malignant peripheral nerve sheath tumour with rhabdomyoblastic differentiation
Granular cell tumour of the sellar region
Composite Hodgkin and non-Hodgkin lymphoma
Primary cutaneous follicle centre lymphoma
Hodgkin lymphoma, mixed cellularity, NOS
Hodgkin lymphoma, lymphocyte depletion, NOS
Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis
Hodgkin lymphoma, lymphocyte depletion, reticular
Hodgkin lymphoma, nodular lymphocyte predominant
Hodgkin lymphoma, nodular sclerosis, NOS
Hodgkin lymphoma, nodular sclerosis, cellular phase
Hodgkin lymphoma, nodular sclerosis, grade 1
Hodgkin lymphoma, nodular sclerosis, grade 2
Malignant lymphoma, mixed small and large cell, diffuse
Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS
T-cell/histiocyte rich large B-cell lymphoma
Indolent T-cell lymphoproliferative disorder of gastrointestinal tract
Subcutaneous panniculitis-like T-cell lymphoma
Primary cutaneous CD4 positive small/medium T-cell lymphoproliferative disorder
Anaplastic large cell lymphoma, T cell and Null cell type
Anaplastic large cell lymphoma, ALK negative
Primary cutaneous CD30+ T-cell lymphoproliferative disorder
Primary cutaneous anaplastic large cell lymphoma
NK/T-cell lymphoma, nasal and nasal-type
Systemic EBV positive T-cell lymphoproliferative disease of childhood
Hydroa vacciniforme-like lymphoproliferative disorder
Primary cutaneous gamma/delta T-cell lymphoma
Precursor cell lymphoblastic lymphoma, NOS
Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease
Langerhans cell histiocytosis, disseminated
IgM monoclonal gammopathy of undetermined significance
Immunoproliferative small intestinal disease
Monoclonal gammopathy of undetermined significance
Angioimmunoblastic lymphadenopathy (AIL)
Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1
Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged
Mixed phenotype acute leukaemia, B/myeloid, NOS
Mixed phenotype acute leukaemia, T/myeloid, NOS
B lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1
B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged
B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)
B lymphoblastic leukaemia/lymphoma with hyperdiploidy
B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL)
B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH
B lymphoblastic leukaemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)
B lymphoblastic leukemia/lymphoma, BCR-ABL1-like
Monoclonal B-cell lymphocytosis, CLL type
B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma
Adult T-cell leukaemia/lymphoma (HTLV-1 positive)
T-cell large granular lymphocytic leukaemia
Precursor cell lymphoblastic leukaemia, NOS
Precursor T-cell lymphoblastic leukaemia
Acute myeloid leukaemia with t(6;9)(p23;q34); DEK-NUP214
Acute promyelocytic leukaemia, t(15;17)(q22;q11-12)
Acute myeloid leukaemia with inv(3)(q21;q26.2) or t(3.3)(q21;q26.2); RPN1-EVI1
Acute myeloid leukaemia with abnormal marrow eosinophils
Acute myeloid leukaemia, minimal differentiation
Acute myeloid leukaemia without maturation
Chronic myelogenous leukaemia, BCR/ABL positive
Atypical chronic myeloid leukaemia, BCR/ABL negative
Acute myeloid leukaemia with mutated NPM1
Acute myeloid leukemia with biallelic mutation of CEBPA
Acute myeloid leukemia with mutated RUNX1
Acute myeloid leukaemia with myelodysplasia-related changes
Acute myeloid leukaemia, t(8;21)(q22;q22)
Acute myeloid leukaemia, 11q23 abnormalities
Myeloid leukaemia associated with Down Syndrome
Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1
Myeloid and lymphoid neoplasms with PDGFRA rearrangement
Myeloid neoplasms with PDGFRB rearrangement
Myeloid and lymphoid neoplasms with FGFR1 abnormalities
Myeloid or lymphoid neoplasm with PCM1-JAK2
Post transplant lymphoproliferative disorder, NOS
Myeloproliferative neoplasm, unclassifiable
Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia
Myelodysplastic syndrome with excess blasts
Refractory anaemia with excess blasts in transformation
Myelodysplastic syndrome with multilineage dysplasia
Myelodysplastic syndrome with isolated del (5q)
Therapy-related myelodysplastic syndrome, NOS
Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia
Myelodysplastic syndrome with single lineage dysplasia